Metaproteomics as a tool to map prebiotic action
Overview
The microbiome plays a crucial role in health, disease, and ecological balance, making its analysis essential for advancements in various fields such as medical research, food industry studies, and environmental science. In this regard, metaproteomics offers a powerful and efficient method to gain rapid insights into both the composition and activity of the microbiome by identifying, characterizing, and quantifying microbial proteins.
This webinar will provide an overview of the sample preparation and mass spectrometry analysis stages involved in metaproteomics. Additionally, it will demonstrate the potential of this approach through a practical case study analyzing the effects of prebiotics on a fecal microbiome. Join us to explore how metaproteomics can enhance your research and provide deeper insights into microbial activity.
Speakers
Morten Danielsen, Ph.D., Head of Metabolomics & Proteomics Business Unit, Cmbio, Copenhagen, Denmark
Morten Danielsen, Ph.D., is the head of the Metabolomics and Proteomics Business unit at Cmbio. He has a scientific background as a microbiologist and has worked with analytical chemistry since 2010. He founded MS-Omics in 2014, together with Lea G. Johnson, which grew into a leading metabolomics provider in Europe. Later MS-Omics merged with Clinical-Microbiomics, CosmosID and DNASense to create a leading microbiome and multi-omics service provider/CRO named Cmbio. Cmbio has labs in Europe and the US, and a global team presence.
Adam Hughes, Key Account Manager, Northern Europe, PreOmics, Manchester, UK
Adam joined PreOmics in 2024, with over 15 years of experience in the life sciences industry. PreOmics offers a comprehensive suite of sample preparation and proteomics solutions. Adam focuses on separation science, particularly sample preparation and chromatography, helping customers optimize their workflows and achieve reliable, reproducible results. Adam’s background includes a Master’s degree in Chemistry and more recently an MBA with the Open University, blending scientific expertise with commercial insight.
Pierre-Olivier Schmit, Proteomics Business Development Manager, Bruker Daltonics, Bordeaux, France
Pierre-Olivier Schmit joined Bruker in 2000 as an MS application and Demo scientist, after a double training in chemistry (Ecole Nationale Supérieure de Chimie de Montpellier) and biochemistry (university of Lund & Montpellier) and a first experience in developing proteomics approaches (CNRS/Pierre Fabre).He took the head of the French demo lab, taking care of customer support, training and demo operations, and reinforcing an expertise in protein characterization and proteomics. He gradually shifted to a market management position from 2012 on, focusing on bottom-up and top-down proteomics approaches. Since 2021, he is acting as a proteomics business development manager for Western, Nordic and southern Europe.
For Research Use Only. Not for use in clinical diagnostic procedures.